본문 바로가기
KERD
논문KCI 등재

Insulin Resistance Is Associated with Early Gastric Cancer: A Prospective Multicenter Case Control Study

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Background/Aims: Recently, increased body weight has been found to be associated with an increasing risk of several cancers, including gastric cancer. The true pathogenic role of hyperglycemia in the development of gastric cancer remains unclear as hyperglycemia and its associated conditions may work as carcinogenic factors. The goal of this study was to clarify the factors associated with early gastric cancer and evaluate a homeostasis model assessment of the insulin resistance (HOMA-IR) index, fasting glucose, and lipid profile as predictors of early gastric cancer. Methods: A total of 63 patients with early gastric cancer between November 2012 and March 2013 were included. Preoperative serum lipid profile levels and serum fasting glucose were examined prospectively in patients with early gastric cancer. The same number of controls were evaluated and matched to the early gastric cancer group for age and gender. We performed multivariate logistic regression analysis to identify independent risk factors for early gastric cancer. Results: Univariate analysis showed that risk for early gastric cancer was associated with diastolic blood pressure (BP), total cholesterol, fasting glucose, and HOMA-IR. In the multivariate-adjusted model, higher total cholesterol, fasting glucose, body mass index, and diastolic BP were strongly associated with an increased risk of early gastric cancer. Conclusions: Hyperglycemia, a lower high-density lipoprotein cholesterol level, and a low HOMA-IR level appear to be associated with early gastric cancer risk.

Abstract

Background/Aims: Recently, increased body weight has been found to be associated with an increasing risk of several cancers, including gastric cancer. The true pathogenic role of hyperglycemia in the development of gastric cancer remains unclear as hyperglycemia and its associated conditions may work as carcinogenic factors. The goal of this study was to clarify the factors associated with early gastric cancer and evaluate a homeostasis model assessment of the insulin resistance (HOMA-IR) index, fasting glucose, and lipid profile as predictors of early gastric cancer. Methods: A total of 63 patients with early gastric cancer between November 2012 and March 2013 were included. Preoperative serum lipid profile levels and serum fasting glucose were examined prospectively in patients with early gastric cancer. The same number of controls were evaluated and matched to the early gastric cancer group for age and gender. We performed multivariate logistic regression analysis to identify independent risk factors for early gastric cancer. Results: Univariate analysis showed that risk for early gastric cancer was associated with diastolic blood pressure (BP), total cholesterol, fasting glucose, and HOMA-IR. In the multivariate-adjusted model, higher total cholesterol, fasting glucose, body mass index, and diastolic BP were strongly associated with an increased risk of early gastric cancer. Conclusions: Hyperglycemia, a lower high-density lipoprotein cholesterol level, and a low HOMA-IR level appear to be associated with early gastric cancer risk.

참고문헌 (42)

  1. Sekikawa A, "Diabetes mellitus increases the risk of early gastric cancer development", Eur J Cancer, 50, pp.2065~2071 (2014)
  2. Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
  3. Park IS, "Clinicopathologic characteristics of early gastric cancer in Korea", Yonsei Med J, 41, pp.607~614 (2000)
  4. Prabhu SR, "Role of Helicobacter pylori in gastric carcinoma", Natl Med J India, 8, pp.58~60 (1995)
  5. Kanauchi M, "A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes", Diabetes Care, 25, pp.1891~1892 (2002)
  6. Alberti KG, "Harmonizing the metabolic syndrome : a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
  7. Harvey AE, "The growing challenge of obesity and cancer : an inflammatory issue", Ann N Y Acad Sci, 1229, pp.45~52 (2011)
  8. Hidaka A, "Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer : the Japan Public Health Center-based prospective study", Int J Cancer, 136, pp.1402~1410 (2015)
  9. Shimoyama S, "Diabetes mellitus carries a risk of gastric cancer : a meta-analysis", World J Gastroenterol, 19, pp.6902~6910 (2013)
  10. Bråkenhielm E, "Adiponectin-induced antiangiogenesis and antitumor activity involve caspasemediated endothelial cell apoptosis", Proc Natl Acad Sci U S A, 101, pp.2476~2481 (2004)
  11. Motoshima H, "Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL", Biochem Biophys Res Commun, 315, pp.264~271 (2004)
  12. Maeda K, "cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1(AdiPose Most abundant Gene transcript 1)", Biochem Biophys Res Commun, 221, pp.286~289 (1996)
  13. Yamauchi T, "Cloning of adiponectin receptors that mediate antidiabetic metabolic effects", Nature, 423, pp.762~769 (2003)
  14. Wallace TM, "Use and abuse of HOMA modeling", Diabetes Care, 27, pp.1487~1495 (2004)
  15. 최은숙, "한국인 남성에서 Homeostasis Model Assessment 표지자로 측정한 인슐린저항성 및 인슐린분비능과 당뇨병 발생위험도", Diabetes and Metabolism Journal, 32(6), pp.498~505 (2008), 대한당뇨병학회
  16. Ikeda F, "Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection : a population-based cohort study", Gastroenterology, 136, pp.1234~1241 (2009)
  17. Yamagata H, "Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population : the Hisayama study", Diabetes Care, 28, pp.789~794 (2005)
  18. Dandona P, "Oxidative damage to DNA in diabetes mellitus", Lancet, 347, pp.444~445 (1996)
  19. Lorenzi M, "High glucose induces DNA damage in cultured human endothelial cells", J Clin Invest, 77, pp.322~325 (1986)
  20. Yi HK, "Expression of the insulin-like growth factors(IGFs)and the IGF-binding proteins(IGFBPs)in human gastric cancer cells", Eur J Cancer, 37, pp.2257~2263 (2001)
  21. Kasuga M, "Report of the Japan diabetes society", Japanese cancer association joint committee on diabetes and cancer, 2013, pp.104, 965~976
  22. Giovannucci E, "Insulin and colon cancer", Cancer Causes Control, 6, pp.164~179 (1995)
  23. Asano K, "Impact of serum total cholesterol on the incidence of gastric cancer in a populationbased prospective study : the Hisayama study", Int J Cancer, 122, pp.909~914 (2008)
  24. Knekt P, "Serum cholesterol and risk of cancer in a cohort of 39, 000 men and women", J Clin Epidemiol, 41, pp.519~530 (1988)
  25. Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention", Cancer Res, 52, pp.6735~6740 (1992)
  26. Aggarwal BB, "Nuclear factor-kappaB : the enemy within", Cancer Cell, 6, pp.203~208 (2004)
  27. Brown DA, "Functions of lipid rafts in biological membranes", Annu Rev Cell Dev Biol, 14, pp.111~136 (1998)
  28. Calleros L, "Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism", Cell Signal, 18, pp.2292~2301 (2006)
  29. Folsom AR, "Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women", Am J Epidemiol, 131, pp.794~803 (1990)
  30. Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999", Biochem Biophys Res Commun, 425, pp.560~564 (2012)
  31. Díez JJ, "The role of the novel adipocyte-derived hormone adiponectin in human disease", Eur J Endocrinol, 148, pp.293~300 (2003)
  32. Hotta K, "Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients", Arterioscler Thromb Vasc Biol, 20, pp.1595~1599 (2000)
  33. Dal Maso L, "Circulating adiponectin and endometrial cancer risk", J Clin Endocrinol Metab, 89, pp.1160~1163 (2004)
  34. Miyoshi Y, "Association of serum adiponectin levels with breast cancer risk", Clin Cancer Res, 9, pp.5699~5704 (2003)
  35. Goktas S, "Prostate cancer and adiponectin", Urology, 65, pp.1168~1172 (2005)
  36. Michalakis K, "Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer : a case control study", Cancer Epidemiol Biomarkers Prev, 16, pp.308~313 (2007)
  37. Ishikawa M, "Plasma adiponectin and gastric cancer", Clin Cancer Res, 11(2 Pt 1), pp.466~472 (2005)
  38. Nakajima TE, "Adipocytokine levels in gastric cancer patients : resistin and visfatin as biomarkers of gastric cancer", J Gastroenterol, 44, pp.685~690 (2009)
  39. Jee Hyun Kang, "Adiponectin Induces Growth Arrest and Apoptosis of MDA-MB-231 Breast Cancer Cell", Archives of Pharmacal Research, 28(11), pp.1263~1269 (2005), 대한약학회
  40. Bub JD, "Adiponectin as a growth inhibitor in prostate cancer cells", Biochem Biophys Res Commun, 340, pp.1158~1166 (2006)
  41. Dieudonne MN, "Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells", Biochem Biophys Res Commun, 345, pp.271~279 (2006)
  42. Ishikawa M, "Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2", Cancer Sci, 98, pp.1120~1127 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (13건)